184 related articles for article (PubMed ID: 35381971)
21. Detection of recurrent, rare, and novel gene fusions in patients with acute leukemia using next-generation sequencing approaches.
Kim B; Kim E; Lee ST; Cheong JW; Lyu CJ; Min YH; Choi JR
Hematol Oncol; 2020 Feb; 38(1):82-88. PubMed ID: 31875988
[TBL] [Abstract][Full Text] [Related]
22. Clinical performance and utility of a comprehensive next-generation sequencing DNA panel for the simultaneous analysis of variants, TMB and MSI for myeloid neoplasms.
Sahajpal NS; Mondal AK; Ananth S; Njau A; Ahluwalia P; Jones K; Ahluwalia M; Okechukwu N; Savage NM; Kota V; Rojiani AM; Kolhe R
PLoS One; 2020; 15(10):e0240976. PubMed ID: 33075099
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML).
Yun S; Geyer SM; Komrokji RS; Al Ali NH; Song J; Hussaini M; Sweet KL; Lancet JE; List AF; Padron E; Sallman DA
Leukemia; 2021 Apr; 35(4):1145-1155. PubMed ID: 32728186
[TBL] [Abstract][Full Text] [Related]
24. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
Ronaghy A; Yang RK; Khoury JD; Kanagal-Shamanna R
Curr Hematol Malig Rep; 2020 Jun; 15(3):194-202. PubMed ID: 32382988
[TBL] [Abstract][Full Text] [Related]
25. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
[TBL] [Abstract][Full Text] [Related]
26. A Review of Molecular and Genetic Diagnostics of Myeloid Malignancies with Emphasis on Diagnostics in Bosnia and Herzegovina.
Kurtovic-Kozaric A; Islamagic E; Asic A; Mehinovic-Cavcic L; Besic L; Sahinbegovic H; Komic H; Kurtovic S; Burazerovic L
Acta Med Acad; 2021 Apr; 50(1):175-196. PubMed ID: 34075772
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive Validation of Diagnostic Next-Generation Sequencing Panels for Acute Myeloid Leukemia Patients.
Wagner U; Wong C; Camenisch U; Zimmermann K; Rechsteiner M; Valtcheva N; Theocharides A; Widmer CC; Manz MG; Moch H; Wild PJ; Balabanov S
J Mol Diagn; 2022 Aug; 24(8):935-954. PubMed ID: 35718092
[TBL] [Abstract][Full Text] [Related]
28. The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing.
Maierhofer A; Mehta N; Chisholm RA; Hutter S; Baer C; Nadarajah N; Pohlkamp C; Thompson ER; James PA; Kern W; Haferlach C; Meggendorfer M; Haferlach T; Blombery P
Blood Adv; 2023 Dec; 7(23):7346-7357. PubMed ID: 37874914
[TBL] [Abstract][Full Text] [Related]
29. Mutational profiling in patients with MDS: ready for every-day use in the clinic?
Bacher U; Kohlmann A; Haferlach T
Best Pract Res Clin Haematol; 2015 Mar; 28(1):32-42. PubMed ID: 25659728
[TBL] [Abstract][Full Text] [Related]
30.
Yin CC; Tam W; Walker SM; Kaur A; Ouseph MM; Xie W; K Weinberg O; Li P; Zuo Z; Routbort MJ; Chen S; Medeiros LJ; George TI; Orazi A; Arber DA; Bagg A; Hasserjian RP; Wang SA
Haematologica; 2024 Jun; 109(6):1825-1835. PubMed ID: 37981812
[TBL] [Abstract][Full Text] [Related]
31. Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement.
Enjeti AK; Agarwal R; Blombery P; Chee L; Chua CC; Grigg A; Hamad N; Iland H; Lane S; Perkins A; Singhal D; Tate C; Tiong IS; Ross DM
Pathology; 2022 Jun; 54(4):389-398. PubMed ID: 35461716
[TBL] [Abstract][Full Text] [Related]
32. Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy.
Ok CY; Leventaki V; Wang SA; Dinardo C; Medeiros LJ; Konoplev S
Am J Clin Pathol; 2016 Feb; 145(2):271-6. PubMed ID: 26800764
[TBL] [Abstract][Full Text] [Related]
33. Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis.
Magaz M; Alvarez-Larrán A; Colomer D; López-Guerra M; García-Criado MÁ; Mezzano G; Belmonte E; Olivas P; Soy G; Cervantes F; Darnell A; Ferrusquía-Acosta J; Baiges A; Turon F; Hernández-Gea V; García-Pagán JC
J Hepatol; 2021 Jan; 74(1):89-95. PubMed ID: 32679300
[TBL] [Abstract][Full Text] [Related]
34. Molecular genetic biomarkers in myeloid malignancies.
Matynia AP; Szankasi P; Shen W; Kelley TW
Arch Pathol Lab Med; 2015 May; 139(5):594-601. PubMed ID: 25152312
[TBL] [Abstract][Full Text] [Related]
35. Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics.
Tefferi A; Skoda R; Vardiman JW
Nat Rev Clin Oncol; 2009 Nov; 6(11):627-37. PubMed ID: 19806146
[TBL] [Abstract][Full Text] [Related]
36. Myelodysplastic/myeloproliferative neoplasms.
Hyjek E; Vardiman JW
Semin Diagn Pathol; 2011 Nov; 28(4):283-97. PubMed ID: 22195406
[TBL] [Abstract][Full Text] [Related]
37. Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.
Bartels S; Schipper E; Hasemeier B; Kreipe H; Lehmann U
Oncotarget; 2016 May; 7(21):30084-93. PubMed ID: 27029036
[TBL] [Abstract][Full Text] [Related]
38. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2).
Wang HY; Rashidi HH
Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325
[TBL] [Abstract][Full Text] [Related]
39. Analytical Validation of an Automated Semiconductor-Based Next-Generation Sequencing Assay for Detection of DNA and RNA Alterations in Myeloid Neoplasms.
Zbieranski N; Insuasti-Beltran G
J Mol Diagn; 2024 Jan; 26(1):29-36. PubMed ID: 37879438
[TBL] [Abstract][Full Text] [Related]
40. Next-generation sequencing-based panel testing for myeloid neoplasms.
Kuo FC; Dong F
Curr Hematol Malig Rep; 2015 Jun; 10(2):104-11. PubMed ID: 25933675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]